2021
DOI: 10.1177/10915818211010490
|View full text |Cite
|
Sign up to set email alerts
|

Exploring Potential Carcinogenic Activity of Per- and Polyfluorinated Alkyl Substances Utilizing High-Throughput Toxicity Screening Data

Abstract: Per- and polyfluorinated alkyl substances (PFAS) are ubiquitous, persistent, and toxic chemicals that pose public health risks. Recent carcinogenicity concerns have arisen based on epidemiological studies, animal tumor findings, and mechanistic data. Thousands of PFAS exist; however, current understanding of their toxicity is informed by studies of a select few, namely, perfluorooctanoic acid and perfluorooctanesulfonic acid. Hence, the computational, high-throughput screening tool, the US EPA CompTox Chemical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 66 publications
(76 reference statements)
0
4
0
Order By: Relevance
“…Higher chain lengths may enhance the toxicity of the pollutants to aquatic invertebrates such as D. magna by increasing the potential for bioaccumulation and biomagnification across trophic levels (Lewis et al, 2022). A previous study observed differences in the metabolic response caused by different polar functional groups (PFCAs vs. PFSAs) present in PFAS (Singh & Hsieh, 2021). Our findings also determined that sublethal exposure to PFAS pollutants of varying chemistries, PFHxA and PFHxS, resulted in differences in the observed perturbations to the extracted polar metabolite profile of D. magna (Figure 1).…”
Section: Discussionmentioning
confidence: 99%
“…Higher chain lengths may enhance the toxicity of the pollutants to aquatic invertebrates such as D. magna by increasing the potential for bioaccumulation and biomagnification across trophic levels (Lewis et al, 2022). A previous study observed differences in the metabolic response caused by different polar functional groups (PFCAs vs. PFSAs) present in PFAS (Singh & Hsieh, 2021). Our findings also determined that sublethal exposure to PFAS pollutants of varying chemistries, PFHxA and PFHxS, resulted in differences in the observed perturbations to the extracted polar metabolite profile of D. magna (Figure 1).…”
Section: Discussionmentioning
confidence: 99%
“…The use of well‐characterized cell lines offers a wide array of possibilities for manipulating experimental variables to obtain a multitude of endpoints in a timely manner. The utility of screening methods employing HTS methods has already been demonstrated for PFAS chemicals (Reardon et al, 2020; Rowan‐Carroll et al, 2021; Singh & Hsieh, 2021). While not inclusive of all assays, endpoints, and cell types, Table 2 provides some examples of approaches that can be and are being used for assessing the human health effects of short‐chain PFAS.…”
Section: Advantages and Limitations Of In Vitro Methodsmentioning
confidence: 99%
“…In human health risk assessments, the weight of evidence narrative for hazard identification often includes qualitative thresholds for the carcinogenic potential of a substance (EPA). Recently, the carcinogenic potential for several PFAS chemicals with sufficient data in ToxCast was explored using the visual analytics software ToxPi (Singh & Hsieh, 2021). Short‐chain alternatives were among the chemicals assessed, and the results demonstrated that, in general, PFAS were found to induce a vast range of biological perturbations associated with carcinogenicity, but structural differences contributed to variability in the results.…”
Section: Advantages and Limitations Of In Vitro Methodsmentioning
confidence: 99%
“…Among different classes of PFAS, long-chain PFAS are the most potent due to the presence of additional C-F bonds. Those containing sulfonic acid derivatives such as sulfonamide and sulfonate PFAS have also been reported as more toxic compounds in terms of carcinogenicity [116]. Investigations found perfluorohexanoate (PFHxA; another type of PFAS) in 100% of whole blood samples, while it was not found in any of the other blood matrices.…”
Section: Carcinogenicity Of Perfluoroalkyl Compoundsmentioning
confidence: 99%